Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiproliferative and Antimigration Activities of Fluoro-Neplanocin A via Inhibition of Histone H3 Methylation in Triple-Negative Breast Cancer
Woong Sub Byun, Won Kyung Kim, Ji-seong Yoon, et al.
Biomolecules (2020) Vol. 10, Iss. 4, pp. 530-530
Open Access | Times Cited: 16

Showing 16 citing articles:

c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL
Ho Yeon Lee, Junghwa Cha, Seon‐Kyu Kim, et al.
Molecular Cancer Research (2018) Vol. 17, Iss. 2, pp. 544-554
Open Access | Times Cited: 67
The Chromatin Response to Double-Strand DNA Breaks and Their Repair
Radoslav Aleksandrov, Rossitsa Hristova, Stoyno Stoynov, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1853-1853
Open Access | Times Cited: 59
Antitumor Activity of Rutaecarpine in Human Colorectal Cancer Cells by Suppression of Wnt/β-Catenin Signaling
Woong Sub Byun, Eun Seo Bae, Won Kyung Kim, et al.
Journal of Natural Products (2022) Vol. 85, Iss. 5, pp. 1407-1418
Closed Access | Times Cited: 25
Role of histone demethylases and histone methyltransferases in triple-negative breast cancer: Epigenetic mnemonics
Janice Jacson Mandumpala, Stephin Baby, Antriya Annie Tom, et al.
Life Sciences (2022) Vol. 292, pp. 120321-120321
Closed Access | Times Cited: 20
Anticancer Activity of Enantiomeric Neplanocins A: Exploring the Role of Chirality in Tumor Suppression
Róża Pawłowska, Hubert Banaszkiewicz, Arkadiusz Chworoś, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1308-1308
Open Access
Accelerated aging in breast cancer survivors and its association with mortality and cancer recurrence
Jingjing Zhu, Fei Wang, Liang Shi, et al.
Breast Cancer Research and Treatment (2020) Vol. 180, Iss. 2, pp. 449-459
Open Access | Times Cited: 25
A novel small molecule STAT3 inhibitor SLSI-1216 suppresses proliferation and tumor growth of triple-negative breast cancer cells through apoptotic induction
Soo Kyoung Park, Woong Sub Byun, Seungbeom Lee, et al.
Biochemical Pharmacology (2020) Vol. 178, pp. 114053-114053
Closed Access | Times Cited: 24
Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells
Woong Sub Byun, Eun Seo Bae, Jinsheng Cui, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 436-436
Open Access | Times Cited: 18
DOT1L promotes expression of CD44 through the Wnt/β-catenin signaling pathway in early gastric carcinoma
Ping Li, Zhou Zhang, Ping Sun
Journal of Cancer (2024) Vol. 15, Iss. 8, pp. 2276-2291
Open Access | Times Cited: 2
Antitumor Activity of Asperphenin B by Induction of Apoptosis and Regulation of Glyceraldehyde-3-phosphate Dehydrogenase in Human Colorectal Cancer Cells
Woong Sub Byun, Eun Seo Bae, Sung Chul Park, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 3, pp. 683-693
Closed Access | Times Cited: 12
Synthesis and biological activity of selenopsammaplin A and its analogues as antitumor agents with DOT1L inhibitory activity
H.‐J. HAN, Woong Sub Byun, Gyu Ho Lee, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 35, pp. 116072-116072
Closed Access | Times Cited: 8
Inhibition of DOT1L by Half-Selenopsammaplin A Analogs Suppresses Tumor Growth and EMT-Mediated Metastasis in Triple-Negative Breast Cancer
Woong Sub Byun, Gyu Ho Lee, Hyeung‐geun Park, et al.
Pharmaceuticals (2020) Vol. 14, Iss. 1, pp. 18-18
Open Access | Times Cited: 8
Metastatic Presentations of Previously Treated Early-Stage Breast Cancer Patients and Association With Survival
Najla Itani, Nicole Grogan, Sarah L. Mott, et al.
Clinical Breast Cancer (2019) Vol. 20, Iss. 3, pp. 209-214
Open Access | Times Cited: 7
Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics
Amiya Das, Pallavi Agarwal, Gaurav Kumar Jain, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 3, pp. 515-550
Closed Access | Times Cited: 5
Test
Neelam Injeti
Future Journal of Pharmaceuticals and Health Sciences (2022) Vol. 2, Iss. 2, pp. 127-131
Open Access
DOT1L Epigenetically Induces the Expression Level of FoxM1 through H3K79me2 and Affects the Malignant Behaviors of Head and Neck Squamous Cell Carcinoma Cells
Huanle Du, Lin Zhang
Journal of Hard Tissue Biology (2022) Vol. 31, Iss. 2, pp. 101-108
Open Access
Page 1

Scroll to top